|
1
|
Benson JR: Management of breast-cancer
patients with sentinel-node micrometastases. Lancet Oncol.
14:266–267. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Atula T, Hunter KD, Cooper LA, Shoaib T,
Ross GL and Soutar DS: Micrometastases and isolated tumour cells in
sentinel lymph nodes in oral and oropharyngeal squamous cell
carcinoma. Eur J Surg Oncol. 35:532–538. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Argiris A, Karamouzis MV, Johnson JT,
Heron DE, Myers E, Eibling D, Cano E, Urba S, Gluckman J, Grandis
JR, et al: Long-term results of a phase III randomized trial of
postoperative radiotherapy with or without carboplatin in patients
with high-risk head and neck cancer. Laryngoscope. 118:444–449.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Tai SK, Li WY, Yang MH, Chang SY, Chu PY,
Tsai TL, Wang YF and Chang PM: Treatment for T1-2 oral squamous
cell carcinoma with or without perineural invasion: Neck dissection
and postoperative adjuvant therapy. Ann Surg Oncol. 19:1995–2002.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Taylor BE, Leibman NF, Luong R, Loar AS
and Craft DM: Detection of carcinoma micrometastases in bone marrow
of dogs and cats using conventional and cell block cytology. Vet
Clin Pathol. 42:85–91. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hirano C, Nagata M, Noman AA, Kitamura N,
Ohnishi M, Ohyama T, Kobayashi T, Suzuki K, Yoshizawa M, Izumi N,
et al: Tetraspanin gene expression levels as potential biomarkers
for malignancy of gingival squamous cell carcinoma. Int J Cancer.
124:2911–2916. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Givi B, Linkov G, Ganly I, Patel SG, Wong
RJ, Singh B, Boyle JO, Shaha AR, Shah JP and Kraus DH: Selective
neck dissection in node-positive squamous cell carcinoma of the
head and neck. Otolaryngol Head Neck Surg. 147:707–715. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mahalingam M, Richards JE, Selim MA,
Muzikansky A and Hoang MP: An immunohistochemical comparison of
cytokeratin 7, cytokeratin 15, cytokeratin 19, CAM 5.2,
carcinoembryonic antigen, and nestin in differentiating
porocarcinoma from squamous cell carcinoma. Hum Pathol.
43:1265–1272. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Alshareeda AT, Soria D, Garibaldi JM,
Rakha E, Nolan C, Ellis IO and Green AR: Characteristics of basal
cytokeratin expression in breast cancer. Breast Cancer Res Treat.
139:23–37. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Guerra A, Marotta V, Deandrea M, Motta M,
Limone PP, Caleo A, Zeppa P, Esposito S, Fulciniti F and Vitale M:
BRAF (V600E) associates with cytoplasmatic localization of p27kip1
and higher cytokeratin 19 expression in papillary thyroid
carcinoma. Endocrine. 44:165–171. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Elalfy H, Basheer T, El-Hussiny AB,
Alsayed SAM and Alhaware G: 639 cytokeratin 18 as a potential
marker predicts early local recurrence of hepatocellular carcinoma
after curative local ablation. J Hepatol. 58:S260–S261. 2013.
View Article : Google Scholar
|
|
12
|
Ichikawa E, Ohnishi T and Watanabe S:
Expression of keratin and involucrin in keratoacanthoma: An
immunohistochemical aid to diagnosis. J Dermatol Sci. 34:115–117.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Helfand BT, Chang L and Goldman RD:
Intermediate filaments are dynamic and motile elements of cellular
architecture. J Cell Sci. 117:133–141. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Shuto M, Warigaya K, Watanabe H, Shimizu
M, Fukuda T and Murata S: Correlation analysis of nuclear
morphology, cytokeratin and Ki-67 expression of urothelial
carcinoma cells. Pathol Int. 63:311–317. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang Y, Zhu JF, Liu YY and Han GP: An
analysis of cyclin D1, cytokeratin 5/6 and cytokeratin 8/18
expression in breast papillomas and papillary carcinomas. Diagn
Pathol. 8:82013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lee CW, Kuo WL, Yu MC, Chen TC, Tsai CN,
Lee WC and Chen MF: The expression of cytokeratin 19 in lymph nodes
was a poor prognostic factor for hepatocellular carcinoma after
hepatic resection. World J Surg Oncol. 11:1362013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Negm H, Mosleh M, Fathy H, Hareedy A and
Elbattawy A: Cytokeratin immunohistochemically detected nodal
micrometastases in N0 laryngeal cancer: Impact on the overall
occult metastases. Eur Arch Otorhinolaryngol. 270:1085–1092. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gazquez C, Ribal MJ, Marín-Aguilera M,
Kayed H, Fernández PL, Mengual L and Alcaraz A: Biomarkers vs
conventional histological analysis to detect lymph node
micrometastases in bladder cancer: A real improvement? BJU Int.
110:1310–1316. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Märkl B, Herbst C, Cacchi C, Schaller T,
Krammer I, Schenkirsch G, Probst A and Spatz H: Prognostic
significance of histologically detected lymph node micrometastases
of sizes between 0.2 and 2 mm in colorectal cancer. Int J
Colorectal Dis. 28:977–983. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chong Loong CY, Mirbagheri N, Harris M and
Fox J: Sentinel node micrometastases in breast cancer: A survey of
Australian and New Zealand breast surgeons. ANZ J Surg. 82:766–767.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Seethala RR: Current state of neck
dissection in the United States. Head Neck Pathol. 3:238–245. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Patel RS, Clark JR, Gao K and OBrien CJ:
Effectiveness of selective neck dissection in the treatment of the
clinically positive neck. Head Neck. 30:1231–1236. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Melkane AE, Mamelle G, Wycisk G, Temam S,
Janot F, Casiraghi O and Lumbroso J: Sentinel node biopsy in early
oral squamous cell carcinomas: A 10-year experience. Laryngoscope.
122:1782–1788. 2012. View Article : Google Scholar : PubMed/NCBI
|
